How automation boosts coagulation testing efficiency

When it comes to extended endocrine therapy, let data drive your decisions for optimal patient outcomes. Bottom line: Using an appropriate test matters! Hologic, Inc. #BustTheMyth #BreastCancerAwarenessMonth

What if diagnosing coronary artery disease, pulmonary hypertension, and heart failure didn’t require a hospital, a specialist, or invasive testing? Episode #312 of MedTech Gurus features Adrian Lam, CFA, CEO of CorVista® Health, who shares how their FDA-cleared, AI-powered platform is transforming frontline cardiac care—delivering accurate, non-invasive diagnostics in under 30 minutes. In this conversation, Adrian explores: • The delicate balance between explainable AI and clinical trust • Strategic lessons on IP protection and clinical validation • Understanding unmet needs—both clinical and operational—for commercial success • Expanding access from rural health to drug monitoring and phenotypic insights • Building business models that align innovation with real-world healthcare delivery For medtech entrepreneurs, investors, and innovators, this episode is packed with strategic insights on scaling AI-driven diagnostics while maintaining clinical credibility and operational excellence. Ready to transform cardiac care at the point of care? #CardiacDiagnostics #MedTech #ArtificialIntelligence #HealthTech #Innovation #PointOfCare #DigitalHealth #MedicalDevices #CardiovascularHealth #ClinicalAI #HealthcareInnovation #AdrianLam #CorVistaHealth #MedTechGurus

Our CEO, Adrian Lam, CFA, joined Med Tech Gurus to share how CorVista Health is redefining cardiac diagnostics with AI and non-invasive innovation. Listen to the full episode to learn how we’re making earlier, smarter diagnosis possible as we enable the future of accessible cardiovascular care. Listen now on: Youtube: https://lnkd.in/gFKJbxfq Apple Podcast: https://lnkd.in/gJq6kziK Spotify: https://lnkd.in/gE9Y_b5M #CardiacDiagnostics #AIinMedicine #MedTech

Personalized Diabetes Care. Powered by GenAI. A leading pharma company joined hands with Axtria to revolutionize diabetes support using GenAI-powered patient coaching. ✅ Boosted patient engagement ✅ Improved medication adherence ✅ Scaled 1:1 coaching with intelligent automation Explore how Generative AI is reshaping chronic care delivery and driving real outcomes: https://bit.ly/3TZxtvP Won Chan Lee, Ph.D | David Hood | Saikat K. Das #Pharma #GenerativeAI #Diabetes #RWE #HEOR

The era of relying solely on the T-score is over. For every chiropractor performing an adjustment, every PT prescribing high-load resistance, and every physician managing long-term bone health, a simple BMD measurement leaves a critical clinical blind spot: Bone Quality. 💥 The Problem: Traditional DEXA uses ionizing radiation, limiting monitoring frequency and failing to assess bone micro-architecture. 💡 The Solution: Echolight REMS Technology. Our technology breaks down the Fragility Score (FS)—a proprietary, radiation-free metric that assesses bone micro-architecture independent of density. It gives you the objective, granular data needed for maximum patient safety. Decoding the Clinical Value: Risk Mitigation: The FS provides a direct 5-year Fracture Risk assessment, enabling you to adjust high-force treatments or rehabilitation protocols confidently. Precision Treatment: You get specific BMD data for each lumbar vertebra (L1-L4), enabling truly targeted interventions. Monitoring Efficacy: Because it is non-ionizing, REMS enables frequent follow-up scans (e.g., every 6 months) to prove the effectiveness of your therapy or pharmaceutical plan objectively. 💡 Clinical Insight: The REMS Fragility Score is the difference between guessing structural integrity and knowing with certainty. This tool is no longer a luxury—it's a clinical imperative for reducing liability and optimizing long-term patient outcomes. #REMS #FragilityScore #BoneHealth #Chiropractic #PhysicalTherapy #HealthcareInnovation #ClinicalData #B2BHealth

Deep Vein Thrombosis (DVT) is a serious and potentially life-threatening condition. Undetected clots can lead to complications such as pulmonary embolism, making early and accurate detection critical. Clinical symptoms of DVT can be subtle or nonspecific, which is why high-performance vascular diagnostic equipment is essential for precise assessments and timely intervention. At MedTech Edge, we provide non-invasive, advanced diagnostic solutions designed for: 🔹 High diagnostic accuracy for confident decision-making 🔹 Real-time waveform output for on-the-spot interpretation 🔹 Compact, portable designs for flexible clinical use 🔹 EHR integration to streamline workflows Our trusted solutions include the Falcon Pro, Falcon Quad, and Falcon Xpress, all of which are engineered for precision, efficiency, and reliability in vascular diagnostics. The right technology improves workflow and saves lives. Find the solution that fits your clinic. Contact MedTech Edge today to learn more. ➡️ https://lnkd.in/gcUTF7Fi #VascularDiagnostics #MedicalTechnology #HealthcareInnovation

Not All Cells Fit the Mould, But Some Still Heal! What Is Non-Conforming CAR-T? CAR-T therapy is a living, personalized treatment. But sometimes, the final product doesn’t meet the expected specs, maybe the cell count is low, the composition is off, or the expansion didn’t go as planned. These are called non-conforming CAR-T products. It’s not a failure, it’s a moment for discernment. The question becomes: Can this product still help the patient safely? Why Non-Conformance Happens • Apheresis issues: Too many neutrophils, not enough CD3+ T cells • Manufacturing challenges: high/low density of CAR, Poor expansion, low transduction, sterility concerns • Patient factors: Prior chemo, high disease burden, immune suppression • Logistics: Delays in transport or cryopreservation What Are Non-Conforming CAR-T Trials? These are clinical studies that intentionally evaluate the use of non-conforming CAR-T products often when no other options exist. Sponsors and investigators may: • Submit deviation reports to regulatory bodies • Justify use based on patient need and risk-benefit analysis • Monitor outcomes closely under protocol-defined safety nets Clinical and Ethical Implications • Patient-centered decisions: Sometimes, a non-conforming product is the only hope. • Regulatory rigor: Every use must be justified, documented, and monitored. • Should learn how to assess risk, document deviations, and communicate clearly with sponsors and families. #CAR_Therapy #NonConformingCART #ClinicalTrials #CellTherapy #OncologyResearch #PharmacistEducator #ApheresisAwareness #Immunotherapy #MentorshipInMedicine #ResearchCoordinator

Advances in diagnostic technology have made healthcare testing faster, more accurate, and more accessible than ever before. Check out this week's PackTalk article and learn more about three key types of diagnostic testing.

Point of Care and Point of Need testing hold much potential to improve the accessibility and efficiency of medical diagnosis. In this white paper, Nick Collier and Simon Thorne look at the sample collection issue and consider how it can be resolved to improve the efficacy of decentralised diagnostic testing. The white paper discusses: - Bridging the gap between sample and test - The benefits of decentralised diagnostic testing - Existing devices for capillary blood collection - Urine sample collection - The benefits of human centred design in diagnostics Read the white paper here: https://lnkd.in/gHBXMZtT #SagentiaMedical #MedTech #Diagnostics

Detect Typhoid accurately with Seromax WIDAL — a reliable diagnostic kit designed for the qualitative and semi-quantitative detection of antibodies to Salmonella typhi and Salmonella paratyphi in human serum. This easy-to-use kit ensures precise results through the tube agglutination technique, helping physicians correlate findings with clinical symptoms and history for better diagnosis and treatment decisions. 🔹 Key Features: • Detects antibodies with high accuracy and sensitivity • Suitable for both qualitative and semi-quantitative testing • Reliable performance and reproducible results • Ideal for clinical laboratories and hospitals • Backed by Avecon’s commitment to innovation and quality Empowering healthcare professionals with dependable diagnostic solutions for better patient outcomes. #SeromaxWidal #aveconhealthcare #widaltest #typhoidtest #typhoiddiagnosis #diagnostics #medicaldevices #healthcareinnovation #clinicaldiagnostics #accurateresults #reliabletesting #medicaltechnology #healthmatters #labtesting #pathologylab #ambala #madeinindia #doctortrusted #diagnosticsolutions #humanhealth